The company’s Phase IIb trial found the therapy, N6LS, was able to maintain viral loads below a detectable threshold.
Customised restaurant recreations, cafe setups, pop-ups by Michelin-star chefs, bespoke table linens with monograms and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback